AEBP1
Adipocyte enhancer-binding protein 1
Also known as: ACLP, AEBP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q8IUX7
- Gene
- AEBP1
- Ensembl
- ENSG00000106624
- Chromosome
- 7
- Canonical length
- 1158 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Nucleoplasm,Vesicles,Cytosol
- Secretome location
- Secreted - unknown location
OverviewNCBI Gene
This gene encodes a member of carboxypeptidase A protein family. The encoded protein may function as a transcriptional repressor and play a role in adipogenesis and smooth muscle cell differentiation. Studies in mice suggest that this gene functions in wound healing and abdominal wall development. Overexpression of this gene is associated with glioblastoma. [provided by RefSeq, May 2013]
Canonical amino-acid sequenceUniProt
1158 residues, UniProt reviewed canonical sequence.
>Q8IUX7|AEBP1
1 MAAVRGAPLL SCLLALLALC PGGRPQTVLT DDEIEEFLEG FLSELEPEPR EDDVEAPPPP
61 EPTPRVRKAQ AGGKPGKRPG TAAEVPPEKT KDKGKKGKKD KGPKVPKESL EGSPRPPKKG
121 KEKPPKATKK PKEKPPKATK KPKEKPPKAT KKPKEKPPKA TKKPPSGKRP PILAPSETLE
181 WPLPPPPSPG PEELPQEGGA PLSNNWQNPG EETHVEAREH QPEPEEETEQ PTLDYNDQIE
241 REDYEDFEYI RRQKQPRPPP SRRRRPERVW PEPPEEKAPA PAPEERIEPP VKPLLPPLPP
301 DYGDGYVIPN YDDMDYYFGP PPPQKPDAER QTDEEKEELK KPKKEDSSPK EETDKWAVEK
361 GKDHKEPRKG EELEEEWTPT EKVKCPPIGM ESHRIEDNQI RASSMLRHGL GAQRGRLNMQ
421 TGATEDDYYD GAWCAEDDAR TQWIEVDTRR TTRFTGVITQ GRDSSIHDDF VTTFFVGFSN
481 DSQTWVMYTN GYEEMTFHGN VDKDTPVLSE LPEPVVARFI RIYPLTWNGS LCMRLEVLGC
541 SVAPVYSYYA QNEVVATDDL DFRHHSYKDM RQLMKVVNEE CPTITRTYSL GKSSRGLKIY
601 AMEISDNPGE HELGEPEFRY TAGIHGNEVL GRELLLLLMQ YLCREYRDGN PRVRSLVQDT
661 RIHLVPSLNP DGYEVAAQMG SEFGNWALGL WTEEGFDIFE DFPDLNSVLW GAEERKWVPY
721 RVPNNNLPIP ERYLSPDATV STEVRAIIAW MEKNPFVLGA NLNGGERLVS YPYDMARTPT
781 QEQLLAAAMA AARGEDEDEV SEAQETPDHA IFRWLAISFA SAHLTLTEPY RGGCQAQDYT
841 GGMGIVNGAK WNPRTGTIND FSYLHTNCLE LSFYLGCDKF PHESELPREW ENNKEALLTF
901 MEQVHRGIKG VVTDEQGIPI ANATISVSGI NHGVKTASGG DYWRILNPGE YRVTAHAEGY
961 TPSAKTCNVD YDIGATQCNF ILARSNWKRI REIMAMNGNR PIPHIDPSRP MTPQQRRLQQ
1021 RRLQHRLRLR AQMRLRRLNA TTTLGPHTVP PTLPPAPATT LSTTIEPWGL IPPTTAGWEE
1081 SETETYTEVV TEFGTEVEPE FGTKVEPEFE TQLEPEFETQ LEPEFEEEEE EEKEEEIATG
1141 QAFPFTTVET YTVNFGDFLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AEBP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.45
- Highest tissue expression
- 1,145 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 1,145 nTPM
- ovary: 248 nTPM
- cervix: 245 nTPM
- endometrium: 226 nTPM
- seminal vesicle: 201 nTPM
- vagina: 191 nTPM
Single-cell type
- peritubular myoid cells: 560 nCPM
- fibroblasts: 307 nCPM
- vascular smooth muscle cells: 246 nCPM
- hepatic stellate cells: 168 nCPM
- pericytes: 162 nCPM
- leydig cells: 151 nCPM
Immune cell
- plasmacytoid DC: 7.6 nTPM
- memory B-cell: 1.6 nTPM
- naive B-cell: 1.4 nTPM
- naive CD4 T-cell: 1 nTPM
- naive CD8 T-cell: 0.5 nTPM
- gdT-cell: 0.3 nTPM
Brain region
- medulla oblongata: 214 nTPM
- hypothalamus: 173 nTPM
- midbrain: 148 nTPM
- spinal cord: 129 nTPM
- white matter: 109 nTPM
- basal ganglia: 88 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about AEBP1.
Disease | AllUniProt
Conditions AEBP1 is implicated in, by any mechanism.
- Ehlers-Danlos syndrome, classic-like, 2 (EDSCLL2) MIM:618000
Disease | GeneticClinVar
46 pathogenic / likely-pathogenic of 809 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Ehlers-Danlos syndrome, classic-like, 2
- Autism spectrum disorder
- AEBP1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.64
- gnomAD pLI
- 0
- gnomAD missense Z
- 1
- DepMap mean gene effect
- -0.08
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- negative regulation of transcription by RNA polymerase II
- proteolysis
- regulation of collagen fibril organization
- regulation of DNA-templated transcription
Molecular functions
- calmodulin binding
- carboxypeptidase activity
- collagen binding
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- RNA polymerase II transcription regulatory region sequence-specific DNA binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Coagulation factor 5/8, C-terminal domain
- Peptidase M14, carboxypeptidase A
- Carboxypeptidase-like, regulatory domain superfamily
- Galactose-binding-like domain superfamily
- Peptidase M14 domain-containing protein
- Zinc carboxypeptidases, zinc-binding region 1
- Zinc carboxypeptidase
- F5/8 type C domain
- Carboxypeptidase regulatory-like domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AEBP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AEBP1 as an antibody target. Whether an autoantibody or antibody against AEBP1 could matter depends on whether native AEBP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AEBP1 is annotated as secreted, so native AEBP1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label AEBP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...